Abstracts by keywords: patient centricity
The digitalization of medicine makes it possible to detect diseases more quickly, monitor them better and take new findings into account promptly when making individual therapy decisions. The chemical and pharmaceutical industries are also facing this change, even though they are in the middle of the commercial economy in terms of digitalization in Germany. The current focus is primarily on the activities of Big Tech companies or digital healthcare start-ups and their approaches to drug development using big data or AI. However, little attention is paid to how the pharmaceutical industry, with its products that often require explanation, positions itself to communicate relevant information about its products and services to patients and medical professionals using digital tools and service innovations. The perspective of the patient without previous medical training must be taken into account, as well as the need for scientifically based information from medical professionals. The following comments are therefore dedicated to these new approaches to medical information.
28.07.2020
First of all, it helps to repeat something that goes without saying: the healthcare system is there for the citizens, especially if they are patients, and not the other way around. Patient-centeredness is therefore the consistent alignment of all actors and their services/contributions as well as processes to the needs of patients1. It cannot be ignored that the term patient-centeredness has been devalued through inflationary use. The authors of this article therefore prefer the term patient orientation. This is the path to a healthcare system that actually aligns its services, including drug supply, with the needs of patients and enables targeted and easy access to these services for patients. The term is also interpreted heterogeneously in the literature.